Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Global Pediatric Vaccines Market By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines), By Indication (Varicella, Diphtheria, Pertussis and Tetanus, Influenza, Human Papilloma Virus, Measles, Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global pediatric vaccine market accounted for $2,1371.73 million in 2021, and is expected to reach $ ... Read More
-
Meningococcal Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the growth of the meningococcal vaccine market include the increase in public-private partnerships to support the development of vaccines at low cost, and rising immunization programs and government initiatives. The COVID-19 pandemic had a significant ... Read More
-
Zika Virus Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... significant impact on the zika virus testing market. Since the beginning of 2020, the Covid-19 pandemic has changed the healthcare system as well as affected the lifestyle of the population worldwide. The spread of infectious ... Read More
-
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Rubella (German Measles) (Infectious Disease) pipeline landscape. Rubella also known as the German measles is an acute, contagious viral infection. The rubella virus is transmitted by airborne droplets ... Read More
-
Global Flu Vaccine Market - 2022-2029
... during the forecast period (2022-2029). The flu vaccine is inactivated, indicating that it includes the killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Flue vaccination is safe ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
... these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug ... Read More
-
Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles), By Region And Segment Forecasts, 2022 - 2030
... The global nanomedicine market is expected to reach USD 427.18 billion by 2030, registering a CAGR of 11.7% during the forecast period, according to a new report by Grand View Research, Inc. The advantages of ... Read More
-
Global Vaccines Market - 2022-2029
... the forecast period (2022-2029). A vaccine is a type of medicine that trains the body’s immune system to fight diseases it has not come into contact with before. Vaccines are developed to prevent disease; when ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User ... Read More
-
Diphtheria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Diphtheria (Infectious Disease) pipeline landscape. Diphtheria is a bacterial infection that affects the membranes of the throat and nose. If left untreated, diphtheria can cause severe damage to kidneys, nervous system, and ... Read More
-
Cryptosporidiosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Cryptosporidiosis (Infectious Disease) pipeline landscape. Cryptosporidiosis is an intestinal illness caused by a microscopic parasite called Cryptosporidium. Symptoms include watery diarrhea, dehydration, and lack of appetite, weight loss, fever, nausea and vomiting. ... Read More
-
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline landscape. Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include ... Read More
-
Global Wearable Injectors Market Size study, By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven, Rotary Pump, Expanding Battery, Other), By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Other), By End User (Hospital, Clinic, Home Care, Other), and Regional Forecasts 2022-2028
... Care, Other), and Regional Forecasts 2022-2028 Global Wearable Injectors Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
-
2022 Certain Infectious and Parasitic Diseases (A00-B99) Global Market Size & Growth Report with Updated Forecasts
... through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell certain infectious and parasitic diseases (a00-b99) combined with country and regional economic, firmographic, and demographic data. ... Read More
-
Blood Testing Market Size By Test Type (Complete Blood Count Test, Kidney Test- Renal Profile, Cholesterol Test- Lipid Profile Test, Blood Glucose Test, Antibodies Test - Rheumatoid Factor, Urine Test, Infectious Disease Screening, Cancer Test, Heart Test), By Product (Instruments, Reagents & Kits, Software), By Method (Manual, Automated), By End-use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Heart Test), By Product (Instruments, Reagents & Kits, Software), By Method (Manual, Automated), By End-use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 ... Read More
-
Global mRNA therapeutics Market Size study, by Application (Rare genetic diseases, Oncology, Respiratory diseases, Infectious disease and others), By Type (Prophylactic Vaccines, Therapeutic Vaccines and Therapeutic Drugs), By End-User (Hospitals & Clinics, Research Organizations and Others) and Regional Forecasts 2022-2028
... Others) and Regional Forecasts 2022-2028 Global mRNA therapeutics Market is valued at approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and ... Read More
-
Middle East and Africa Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The MEA Anti-infective agents market was valued at US$ 8,188.65 million in ... Read More
-
Drug Discovery Market Forecasts to 2028 – Global Analysis by Technology (Nanotechnology, High Throughput Screening, Combinatorial Chemistry, Pharmacogenomics, Bioanalytical Instruments, Biochips, Bioinformatics and Other Technologies), Service (Medicinal Chemical Services, Biological Services, Drug Metabolism and Pharmacokinetics (DMPK) Services and Other Pharmaceutical Services), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Therapeutic Area (Respiratory Disease, Neurology, Infectious and Immune System Diseases, Oncology, Cardiovascular Diseases, Digestive System Diseases, Diabetes and Other Therapeutic Areas) , End Use and By Geography
... (DMPK) Services and Other Pharmaceutical Services), Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), Therapeutic Area (Respiratory Disease, Neurology, Infectious and Immune System Diseases, Oncology, Cardiovascular Diseases, Digestive System Diseases, Diabetes ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 300,000 diagnosed incidence cases of HAP across seven major pharmaceutical markets. There are six leading marketed drugs for the treatment of HAP, and Merck is a key player in the ... Read More
-
Infectious Disease Diagnostics- Market Insights, Competitive Landscape and, Market Forecast - 2027
... By Application (Viral Diseases, Bacterial Diseses, And Others) By End-User (Hosptials, Diagnostic Labs, And Others) by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to surge in prevalence of ... Read More
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, Rapid Test, Western Blotting, ELISPOT), Specimen (Blood, Saliva), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) - Global Forecasts to 2027
... market is valued at an estimated USD 40.2 billion in 2022 and is projected to reach USD 49.6 billion by 2027, at a CAGR of 4.3% during the forecast period. Market growth is driven by ... Read More
-
Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)
... Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) The global lyophilized injectable market is projected to reach US$ 4,001.27 ... Read More
-
Infectious Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Technique (Traditional, Molecular), End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Academic Research Institutes) and By Geography
... Disease Diagnostics Market is accounted for $30.69 billion in 2022 and is expected to reach $52.03 billion by 2028 growing at a CAGR of 9.2% during the forecast period. Disease diagnostics are used for confirmation ... Read More
Research Assistance
